Harmony Biosciences Holdings (HRMY) Accounts Payables (2019 - 2026)
Harmony Biosciences Holdings (HRMY) posted Accounts Payables of $28.6 million for Q1 2026, up 61.65% sequentially from $17.7 million in Q4 2025, and up 63.81% YoY from $17.5 million in Q1 2025.
Harmony Biosciences Holdings (HRMY) Accounts Payables (2019 - 2026) Analysis & Trends
Harmony Biosciences Holdings has reported Accounts Payables for 8 years, with the latest figure at $28.6 million in Q1 2026.
- Quarterly Accounts Payables rose 63.81% year-over-year to $28.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $28.6 million (up 63.81% YoY) and the FY2025 annual result came in at $17.7 million, up 28.73% from the prior year.
- Accounts Payables grew to $28.6 million in Q1 2026 per HRMY's latest filing, from $17.7 million in the prior quarter.
- Over five years, Accounts Payables peaked at $28.6 million in Q1 2026 and troughed at $3.8 million in Q4 2022.
- A 5-year average of $14.4 million and a median of $13.7 million in 2024 frame the typical range for Accounts Payables.
- The widest YoY moves for Accounts Payables: up 368.3% in 2023, down 34.93% in 2023.
- Over 5 years, Accounts Payables stood at $3.8 million in 2022, then jumped by 368.3% to $17.7 million in 2023, then retreated by 22.48% to $13.7 million in 2024, then advanced by 28.73% to $17.7 million in 2025, then surged by 61.65% to $28.6 million in 2026.
- According to Business Quant data, Accounts Payables over the past three periods registered $28.6 million, $17.7 million, and $26.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.52 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 88.42 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 470.30 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3.05 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 35.57 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 108.02 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 428.93 Mn |
| 10 | Harmony Biosciences Holdings | 2.22 Bn | 1.41 Bn | 198.08 Mn | 21.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 21.68 Mn |
| Mar 31, 2026 | 28.60 Mn |
| Dec 31, 2025 | 17.69 Mn |
| Sep 30, 2025 | 26.34 Mn |
| Jun 30, 2025 | 28.30 Mn |
| Mar 31, 2025 | 17.46 Mn |
| Dec 31, 2024 | 13.74 Mn |
| Sep 30, 2024 | 10.53 Mn |
| Jun 30, 2024 | 22.68 Mn |
| Mar 31, 2024 | 15.14 Mn |
| Dec 31, 2023 | 17.73 Mn |
| Sep 30, 2023 | 6.54 Mn |
| Jun 30, 2023 | 6.56 Mn |
| Mar 31, 2023 | 6.41 Mn |
| Dec 31, 2022 | 3.79 Mn |
| Sep 30, 2022 | 10.05 Mn |
| Jun 30, 2022 | 6.66 Mn |
| Mar 31, 2022 | 6.90 Mn |
| Dec 31, 2021 | 1.00 Mn |
| Sep 30, 2021 | 4.18 Mn |